
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products

Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package

TRAIN Newsletter — December 2022

End of Year Legislative Package – Health Provisions

FinTech in Focus—November 1, 2022

FasterCures Quarterly Update: October 2022

Web3, Sensible Regulation, and Asia Pacific's Global Competitiveness

Global Leaders, Experts, and Cultural Icons Convene at The Milken Institute Asia Summit to Celebrate a Transformed World

Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs

Viewing the World’s Thorniest Problems through a Prism of Opportunity

The Future of the Blockchain Industry Is Undoubtedly Bright
